Platelet transfusion for low platelet counts in blood cancer patients
Part of Blood & lymphatic clinical trials.
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer or bone marrow failure causing very low platelet counts.
- You need a platelet transfusion because of your low platelet count.
- You can recognize and report any bleeding symptoms you have.
- You agree to take part in the study.
- You are registered with the French social security system or eligible for it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This trial tests whether giving platelet transfusions to critically ill patients with very low platelet counts helps prevent bleeding. If you are in the ICU with low platelets and need life support, this study may be relevant to you.
This study uses a special blood test to create a score that predicts bleeding risk in patients with blood cancers and very low platelet counts. It could help doctors decide if you need extra care to prevent bleeding.
This trial tests whether a one-time infusion of umbilical cord blood cells can safely raise platelet counts in people whose counts dropped after cancer treatment. It is for patients whose low platelets are clearly linked to their cancer therapy and who have no other major health problems.
This trial studies how best to prevent and treat dangerous blood clots in people with cancer who also have very low platelets. It may help guide safer blood-thinner treatment when bleeding risk is high.
This trial tests how a platelet transfusion affects blood vessel function in intensive care patients with low platelet counts (thrombocytopenia). It may help doctors understand if transfusions help the tiny blood vessels work better.
Hear when a new Thrombocytopaenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.